Insmed (INSM) Payables (2010 - 2026)

Insmed's Payables history runs 17 years deep, the most recent figure standing at $352.6 million for Q1 2026.

• On a quarterly basis, Payables rose 51.52% year-over-year to $352.6 million in Q1 2026; TTM through Mar 2026 was $352.6 million, a 51.52% increase from a year earlier, with the FY2025 full-year figure at $456.1 million, up 59.9% from the prior year.
• Payables eased to $352.6 million in Q1 2026 per INSM's latest filing, from $456.1 million in the prior quarter.
• Across five years, Payables topped out at $456.1 million in Q4 2025 and bottomed at $31.1 million in Q2 2022.
• The 5-year median for Payables is $258.9 million (2024), against an average of $251.8 million.
• Biggest YoY gain for Payables was 116.62% in 2022; the steepest drop was 0.2% in 2022.
• Year by year, Payables stood at $182.1 million in 2022, then advanced by 18.05% to $215.0 million in 2023, then soared by 32.66% to $285.2 million in 2024, then surged by 59.9% to $456.1 million in 2025, then retreated by 22.7% to $352.6 million in 2026.
• Per Business Quant, the three latest INSM Payables figures stand at $352.6 million (Q1 2026), $456.1 million (Q4 2025), and $409.8 million (Q3 2025).